Stuart McKellar

Patent Scientist

Stuart McKellar

Prior to joining EIP Stuart worked as a Postdoctoral Research Associate at King’s College London following completion of his PhD in cell biology at the University of Edinburgh.

When working as a Postdoctoral Research Associate, Stuart studied how different strains of influenza virus overcome the human immune system. During his PhD, he developed a novel method to interrogate how infectious bacteria adapt to the human bloodstream.

Published articles

  • August 2023
    EIP Updates, #Barbenheimer: A Tale of Patents, Designs and Possibilities (link)
  • 2022
    Nature Communications, RNase III CLASH in MRSA uncovers sRNA regulatory networks coupling metabolism to toxin expression (link)
  • 2020
    Journal of Visualized Experiments, Monitoring Protein-RNA Interaction Dynamics In Vivo at High Temporal Resolution Using χCRAC (link)
  • 2020
    University of Edinburgh, Identification of non-coding RNA interactions that dictate Staphylococcus aureus virulence, (link)

Education and qualifications

  • 2016 — 2020
    Ph.D in cell biology, University of Edinburgh
  • 2015 — 2016
    M.Res in cell biology, University of Edinburgh
  • 2010 — 2015
    M.Sci (Hons) in molecular and cellular biology, University of Glasgow

Career history

  • 2023 — present
    Patent Scientist, EIP
  • 2021 — 2023
    Postdoctoral Research Associate, King’s College London

Awards and recognition

  • Andrew Jamieson Prize for most distinguished graduate at University of Glasgow.
  • IBM Data Science Professional Certificate - machine learning, data analytics and data communication.

Speaking engagements

  • September 2022
    RNA 3' end formation and the regulation of eukaryotic genomes, Alternative mechanisms of influenza A virus-induced transcription termination defects
  • August 2019
    Gordon Research Conference on Staphylococcal Diseases, Identification of non-coding RNA interactions that dictate Staphylococcus aureus virulence



  • Biotech
  • Cell therapy
  • Gene editing
  • Immunotherapy